Journal of Cancer Research and Clinical Oncology

Search all Journal of Cancer Research and Clinical Oncology articles

Volume 148, Issue 5

May 2022

26 articles in this issue

Statistical recomendations for the authors of manuscripts submitted to the Journal of Cancer Research and Clinical Oncology
Michal Ordak
Guest Editorial 03 March 2022 Pages: 1011 - 1013
Radiotherapy resistance: identifying universal biomarkers for various human cancers
Irina Larionova
Militsa Rakina
Evgeny Denisov
Review – Cancer Research 03 February 2022 Pages: 1015 - 1031
The 3D in vivo chorioallantoic membrane model and its role in breast cancer research
Cynthia Kohl
Thiha Aung
Thomas Papathemelis
Review – Cancer Research 05 February 2022 Pages: 1033 - 1043
Ex vivo propagation in a novel 3D high-throughput co-culture system for multiple myeloma
Johannes M. Waldschmidt
Stefan J. Fruttiger
Monika Engelhardt
Original Article – Cancer Research Open access 24 January 2022 Pages: 1045 - 1055
Prevalence of diabetes mellitus among 80,193 gastrointestinal cancer patients in five European and three Asian countries
Christoph Roderburg
Sven H. Loosen
Karel Kostev
Original Article – Cancer Research Open access 12 December 2021 Pages: 1057 - 1062
Estrogen concentration and estrogen receptor-β expression in postmenopausal colon cancer considering patient/tumor background
Naoko Honma
Tomio Arai
Tetuo Mikami
Original Article – Cancer Research 15 January 2022 Pages: 1063 - 1071
In vivo and in vitro inhibition of SCLC by combining dual cancer-specific recombinant adenovirus with Etoposide
Tingyu Li
Jinbo Fang
Xiao Li
Original Article – Cancer Research 17 January 2022 Pages: 1073 - 1085
Socioeconomic disparities in endometrial cancer survival in Germany: a survival analysis using population-based cancer registry data
Ahmed Bedir
Semaw Ferede Abera
Daniel Medenwald
Original Article – Cancer Research Open access 22 January 2022 Pages: 1087 - 1095
Immunotherapy maintenance therapy for advanced urothelial carcinoma (aUC): a comprehensive review
Lucia Carril-Ajuria
Maria Cruz Martin-Soberón
Daniel Castellano
Review – Clinical Oncology 22 January 2022 Pages: 1097 - 1105
Therapeutic approach for digestive system cancers and potential implications of exercise under hypoxia condition: what little is known? a narrative review
Sergio Pérez Regalado
Josefa León
Belén Feriche
Review – Clinical Oncology 14 February 2022 Pages: 1107 - 1121
Complementary and alternative medicine (CAM) supplements in cancer outpatients: analyses of usage and of interaction risks with cancer treatment
Clemens P. J. G. Wolf
Tobias Rachow
Jutta Huebner
Original Article – Clinical Oncology Open access 06 July 2021 Pages: 1123 - 1135
Epithelial circulating tumor cells with a heterogeneous phenotype are associated with metastasis in NSCLC
Yujuan Zhang
Yu Men
Wei Cui
Original Article – Clinical Oncology Open access 13 July 2021 Pages: 1137 - 1146
Overuse of follow-up chest computed tomography in patients with incidentally identified nodules suspicious for lung cancer
Ran Guo
Yang Zhang
Haiquan Chen
Original Article – Clinical Oncology 08 July 2021 Pages: 1147 - 1152
Multi-institutional survey of malignant pleural mesothelioma patients in the Hokushin region
Hidetaka Uramoto
Tomoya Takiguchi
Seiji Yano
Original Article – Clinical Oncology 29 June 2021 Pages: 1153 - 1158
Efficacy and safety of anti-PD-1 inhibitor combined with nab-paclitaxel in Chinese patients with refractory melanoma
Jing-jing Li
Jiu-hong Wang
Xiao-shi Zhang
Original Article – Clinical Oncology 28 June 2021 Pages: 1159 - 1169
Dexa-BEAM versus MIFAP as salvage regimen for recurrent lymphoma: a prospective randomized multicenter phase II trial with a median follow-up of 14.4 years
Sabine Kürzel
André-René Blaudszun
Mathias Hänel
Original Article – Clinical Oncology 26 June 2021 Pages: 1171 - 1181
Epithelial–mesenchymal transition (EMT) in vulvar cancer with and without inguinal lymph node involvement
Christine E. Brambs
Lars-Christian Horn
Anne Kathrin Höhn
Original Article – Clinical Oncology Open access 08 September 2021 Pages: 1183 - 1193
The efficacy of immune checkpoint inhibitors in advanced hepatocellular carcinoma: a meta-analysis based on 40 cohorts incorporating 3697 individuals
Rixiong Wang
Nan Lin
Qing Wu
Original Article – Clinical Oncology 23 July 2021 Pages: 1195 - 1210
Hepatitis B surface antigen positivity is associated with progression of disease within 24 months in follicular lymphoma
Chieh-Lung Cheng
Wei-Quan Fang
Hwei-Fang Tien
Original Article – Clinical Oncology 06 July 2021 Pages: 1211 - 1222
Short-term outcome of Ivor Lewis esophagectomy following neoadjuvant chemoradiation versus perioperative chemotherapy in patients with locally advanced adenocarcinoma of the esophagus and gastroesophageal junction: a propensity score-matched analysis
Patrick Sven Plum
Alexander Damanakis
Marc Bludau
Original Article – Clinical Oncology Open access 05 July 2021 Pages: 1223 - 1234
The eagle sign: a new preoperative MRI-based tool for predicting topographic correlation between craniopharyngioma and hypothalamus
ShaoYang Li
Le Yang
Tao Hong
Original Article – Clinical Oncology 09 October 2021 Pages: 1235 - 1249
Correction to: The eagle sign: a new preoperative MRI-based tool for predicting topographic correlation between craniopharyngioma and hypothalamus
ShaoYang Li
Le Yang
Tao Hong
Correction 02 December 2021 Pages: 1251 - 1252
Efficacy of single-site radiotherapy plus PD-1 inhibitors vs PD-1 inhibitors for oligometastatic non-small cell lung cancer
Peiliang Wang
Tianwen Yin
Feifei Teng
Original Article – Clinical Oncology Open access 23 November 2021 Pages: 1253 - 1261
Correction to: Efficacy of single-site radiotherapy plus PD-1 inhibitors vs PD-1 inhibitors for oligometastatic non-small cell lung cancer
Peiliang Wang
Tianwen Yin
Feifei Teng
Correction Open access 08 December 2021 Pages: 1263 - 1263
Afatinib, an effective treatment for patient with lung squamous cell carcinoma harboring uncommon EGFR G719A and R776C co-mutations
Chao Han
Xuan Ding
Chengwei Wang
Letter to the Editor 01 March 2022 Pages: 1265 - 1268
Reversing resistance to immune checkpoint inhibitor by adding recombinant human adenovirus type 5 in a patient with small cell lung cancer with promoted immune infiltration: a case report
Qi Zhao
Jingzhi Tong
Liyun Miao
Letter to the Editors 25 February 2022 Pages: 1269 - 1273

Volume 148, Issue 5

Statistical recomendations for the authors of manuscripts submitted to the Journal of Cancer Research and Clinical Oncology

Radiotherapy resistance: identifying universal biomarkers for various human cancers

The 3D in vivo chorioallantoic membrane model and its role in breast cancer research

Ex vivo propagation in a novel 3D high-throughput co-culture system for multiple myeloma

Prevalence of diabetes mellitus among 80,193 gastrointestinal cancer patients in five European and three Asian countries

Estrogen concentration and estrogen receptor-β expression in postmenopausal colon cancer considering patient/tumor background

In vivo and in vitro inhibition of SCLC by combining dual cancer-specific recombinant adenovirus with Etoposide

Socioeconomic disparities in endometrial cancer survival in Germany: a survival analysis using population-based cancer registry data

Immunotherapy maintenance therapy for advanced urothelial carcinoma (aUC): a comprehensive review

Therapeutic approach for digestive system cancers and potential implications of exercise under hypoxia condition: what little is known? a narrative review

Complementary and alternative medicine (CAM) supplements in cancer outpatients: analyses of usage and of interaction risks with cancer treatment

Epithelial circulating tumor cells with a heterogeneous phenotype are associated with metastasis in NSCLC

Overuse of follow-up chest computed tomography in patients with incidentally identified nodules suspicious for lung cancer

Multi-institutional survey of malignant pleural mesothelioma patients in the Hokushin region

Efficacy and safety of anti-PD-1 inhibitor combined with nab-paclitaxel in Chinese patients with refractory melanoma

Dexa-BEAM versus MIFAP as salvage regimen for recurrent lymphoma: a prospective randomized multicenter phase II trial with a median follow-up of 14.4 years

Epithelial–mesenchymal transition (EMT) in vulvar cancer with and without inguinal lymph node involvement

The efficacy of immune checkpoint inhibitors in advanced hepatocellular carcinoma: a meta-analysis based on 40 cohorts incorporating 3697 individuals

Hepatitis B surface antigen positivity is associated with progression of disease within 24 months in follicular lymphoma

Short-term outcome of Ivor Lewis esophagectomy following neoadjuvant chemoradiation versus perioperative chemotherapy in patients with locally advanced adenocarcinoma of the esophagus and gastroesophageal junction: a propensity score-matched analysis

The eagle sign: a new preoperative MRI-based tool for predicting topographic correlation between craniopharyngioma and hypothalamus

Correction to: The eagle sign: a new preoperative MRI-based tool for predicting topographic correlation between craniopharyngioma and hypothalamus

Efficacy of single-site radiotherapy plus PD-1 inhibitors vs PD-1 inhibitors for oligometastatic non-small cell lung cancer

Correction to: Efficacy of single-site radiotherapy plus PD-1 inhibitors vs PD-1 inhibitors for oligometastatic non-small cell lung cancer

Afatinib, an effective treatment for patient with lung squamous cell carcinoma harboring uncommon EGFR G719A and R776C co-mutations

Reversing resistance to immune checkpoint inhibitor by adding recombinant human adenovirus type 5 in a patient with small cell lung cancer with promoted immune infiltration: a case report

Journal navigation